AB1536 MYCOPHENOLATE MOFETIL VERSUS RITUXIMAB IN THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES | Publicación